Canadian medical cannabis producer Aphria has signed an exclusive supply agreement with an Argentinian-based pharmaceutical import and distribution firm to provide medical cannabis products in the Latin American nation.
“We are excited to enter the Argentinian market through this initial supply agreement. We see tremendous potential for medical cannabis in several emerging markets in South America, including Argentina. As the leading low-cost supplier of high-quality medical cannabis, Aphria will continue to expand its global leadership through strategic investments, partnerships and exclusive agreements such as this one.” – Vic Neufeld, Aphria CEO, in a press release
In January, Aphria announced it would acquire Nuuvera Inc. as part of its global expansion plans. Nuuvera already has relationships in Germany, Italy, the United Kingdom, Spain, Israel, Malta, Lesotho, and Uruguay; while Aphria currently has agreements in Australia. The Nuuvera deal has yet to be finalized.
Aphria is also one of three firms to strike a deal with Shoppers Drug Mart, Canada’s largest provider of pharmacy products and services, to sell its products through the retailer. The company is also one of six chosen by the Quebec government to supply recreational cannabis to the government, which will be distributed to licensed outlets.
Neither the name of the Argentinian import company nor the monetary terms of the deal have been disclosed.